Theravance Biopharma (TBPH) Asset Utilization Ratio (2014 - 2026)

Theravance Biopharma (TBPH) has 13 years of Asset Utilization Ratio data on file, last reported at 0.19 in Q1 2026.

• Asset Utilization Ratio for Q1 2026 came in at 0.19, down 0.8% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.19 (down 0.8% YoY), and the FY2025 annual result was 0.02, down 89.79% from the prior year.
• Asset Utilization Ratio retreated to 0.19 in Q1 2026 per TBPH's latest filing, from 0.19 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 0.2 in Q2 2025 and troughed at 0.06 in Q4 2022.
• A 5-year average of 0.15 and a median of 0.16 in 2024 frame the typical range for Asset Utilization Ratio.
• The sharpest annual moves came in 2022 and 2023: Asset Utilization Ratio tumbled 58.3% in 2022, then soared 143.42% in 2023.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.06 in 2022, then soared by 143.42% to 0.14 in 2023, then gained by 25.58% to 0.18 in 2024, then gained by 6.0% to 0.19 in 2025, then fell by 3.42% to 0.19 in 2026.
• Business Quant data shows TBPH's Asset Utilization Ratio at 0.19 in Q1 2026, 0.19 in Q4 2025, and 0.19 in Q3 2025.